Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 5.415% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a. Cc1ccc2nc(C)cc(Cl)c2c1
b. COc1cccc2oc3cc(-c4ccc5[nH]ccc5c4)ccc3c(=O)c12
c. Nc1c(-c2ccc(Cl)cc2)cnn1-c1ccc(Cc2ccc(Cl)cc2Cl)nn1
d. COC1CCN(Cc2c(C(=O)N3CCN(C4CCCCC4)CC3)nc3ccccn23)CC1
e. Cc1cc(C(=O)N2CCN(S(C)(=O)=O)CC2)sc1-c1ccccc1
Answer: d. COC1CCN(Cc2c(C(=O)N3CCN(C4CCCCC4)CC3)nc3ccccn23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC1CCN(Cc2c(C(=O)N3CCN(C4CCCCC4)CC3)nc3ccccn23)CC1
COC1CCN(Cc2c(C(=O)N3CCN(C4CCCCC4)CC3)nc3ccccn23)CC1
(4-cyclohexylpiperazin-1-yl)-[3-[(4-methoxypiperidin-1-yl)methyl]imidazo[1,2-a]pyridin-2-yl]methanone